Dendrimer as nanocarrier for drug delivery

被引：835

作者：

Kesharwani, Prashant ^{[1
]}

Jain, Keerti ^{[1
]}

Jain, Narendra Kumar ^{[1
]}

机构：

[1] Dr Hari Singh Gour Cent Univ, Dept Pharmaceut Sci, Pharmaceut Res Lab, Sagar 470003, MP, India

来源：

PROGRESS IN POLYMER SCIENCE | 2014年 / 39卷 / 02期

关键词：

Dendrimer; Toxicity; PAMAM; PPI; Drug delivery; Biocompatibility; POLY(PROPYLENE IMINE) DENDRIMERS; MACROMOLECULAR CONTRAST AGENT; ATOMIC-FORCE MICROSCOPY; WALLED CARBON NANOTUBE; PAMAM DENDRIMER; IN-VITRO; POLY(AMIDOAMINE) DENDRIMERS; MAGNETIC-RESONANCE; TRANSEPITHELIAL TRANSPORT; PEPTIDE DENDRIMERS;

D O I：

10.1016/j.progpolymsci.2013.07.005

中图分类号：

O63 [高分子化学（高聚物）];

学科分类号：

070305 ; 080501 ; 081704 ;

摘要：

Dendrimers are novel three dimensional, hyperbranched globular nanopolymeric architectures. Attractive features like nanoscopic size, narrow polydispersity index, excellent control over molecular structure, availability of multiple functional groups at the periphery and cavities in the interior distinguish them amongst the available polymers. Applications of dendrimers in a large variety of fields have been explored. Drug delivery scientists are especially enthusiastic about possible utility of dendrimers as drug delivery tool. Terminal functionalities provide a platform for conjugation of the drug and targeting moieties. In addition, these peripheral functional groups can be employed to tailor-make the properties of dendrimers, enhancing their versatility. The present review highlights the contribution of dendrimers in the field of nanotechnology with intent to aid the researchers in dendrimers in the field of drug delivery. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：268 / 307

页数：40

共 256 条

[41] Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers [J].

Crampton, Hannah L. ;

Simanek, Eric E. .

POLYMER INTERNATIONAL, 2007, 56 (04) :489-496

[42] Oxygen reduction and diffusion in electroactive nanostructured membranes (ENM) using a layer-by-layer dendrimer-gold nanoparticle approach [J].

Crespilho, Frank N. ;

Nart, Francisco C. ;

Oliveira, Osvaldo N., Jr. ;

Brett, Christopher M. A. .

ELECTROCHIMICA ACTA, 2007, 52 (14) :4649-4653

[43]

Csaba Noemi, 2006, Expert Opin Drug Deliv, V3, P463, DOI 10.1517/17425247.3.4.463

[44] The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability [J].

D'Emanuele, A ;

Jevprasesphant, R ;

Penny, J ;

Attwood, D .

JOURNAL OF CONTROLLED RELEASE, 2004, 95 (03) :447-453

[45] Peptide dendrimers as artificial enzymes, receptors, and drug-delivery agents [J].

Darbre, Tamis ;

Reymond, Jean-Louis .

ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (12) :925-934

[46] Vehicles for oligonucleotide delivery to tumours [J].

Dass, CR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (01) :3-27

[47]

De Brabander-van den Berg EMM, 1993, ANGEW CHEM INT ED EN, V32, P1308

[48] Polyester dendritic systems for drug delivery applications:: In vitro and in vivo evaluation [J].

De Jesús, OLP ;

Ihre, HR ;

Gagne, L ;

Fréchet, JMJ ;

Szoka, FC .

BIOCONJUGATE CHEMISTRY, 2002, 13 (03) :453-461

[49] Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins [J].

Devarakonda, B ;

Hill, RA ;

Liebenberg, W ;

Brits, M ;

de Villiers, MM .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 304 (1-2) :193-209

[50] Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes [J].

Devarakonda, Bharathi ;

Otto, Daniel P. ;

Judefeind, Anj A. ;

Hill, Ronald A. ;

de Villiers, Melgardt M. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 345 (1-2) :142-153

← 1 2 3 4 5 6 7 8 9 10 →